Search Results for 'astellas'
-
Breaking News | Drug Development | Industry News
Astellas Pharma Acquires Potenza Therapeutics
Successful collaboration results in three INDs with the potential to treat various cancers12.17.18
-
Industry News | Promotions & Moves
Astellas Announces Key Promotion
Geoff Towle has been promoted to vice president, Oncology Marketing, Astellas US09.19.18
-
Promotions & Moves
Astellas Appoints Latin America VP
Fernandez responsible for leading operations and growth across Latin America08.24.18
-
Drug Development | Industry News
-
Bio News | Industry News | Promotions & Moves
Astellas Announces Management Changes
The changes include the positions of VP, Oncology, Medical Affairs, and VP, & executive director, Corporate Communications07.24.18
-
cGMP Manufacture | Collaborations & Alliances | Drug Development | Facilities | Industry News
Eurofins, Astellas Sign Outsourcing Agreement
Astellas has committed to provide ASL work covering its current capacity for an agreed period of time05.29.18
-
Promotions & Moves
Astellas Pharma Names Americas Ops President
Barretto-Ko to lead the company's North and South America operations03.15.18
-
Clinical Trials | Drug Development | Promotions & Moves
Astellas Appoints Three Senior Development Heads
Fleishaker, Gronen, and Krivoshik to lead clinical, data, and oncology departments05.01.17
-
Promotions & Moves
Astellas Names Government Affairs and Policy VP
Devaney to implement federal and state government strategies in the Americas07.12.16
-
16 Astellas Pharma
#16. Astellas Pharma 3-11, Nihonbashi-honcho 2-chome, Chuo-ku Tokyo, 103-8411 Japan Tel: (81) 3 3244 3000 Fax: (81) 3 3244 3272 www.astellas.com Headcount 15,000 Year Established…07.12.06
